rolipram has been researched along with Chemical and Drug Induced Liver Injury in 2 studies
Chemical and Drug Induced Liver Injury: A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rolipram is a specific type IV phosphodiesterase inhibitor that suppresses the activity of immune cells and the production of pro-inflammatory cytokines." | 1.33 | Specific type IV phosphodiesterase inhibitor ameliorates thioacetamide-induced liver injury in rats. ( Hatakeyama, N; Horikawa, Y; Jin, M; Komatsu, K; Konishi, N; Matsuhashi, T; Odashima, M; Ohba, R; Otaka, M; Oyake, J; Sato, T; Wada, I; Watanabe, S, 2005) |
| "Rolipram is a type IV phosphodiesterase inhibitor endowed with powerful immunomodulatory properties." | 1.30 | Prevention by rolipram of concanavalin A-induced T-cell-dependent hepatitis in mice. ( Beltrami, B; Di Marco, R; Di Mauro, M; Magro, G; Meroni, PL; Nicoletti, F; Xiang, M; Zaccone, P, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuhashi, T | 1 |
| Otaka, M | 1 |
| Odashima, M | 1 |
| Jin, M | 1 |
| Komatsu, K | 1 |
| Konishi, N | 1 |
| Wada, I | 1 |
| Sato, T | 1 |
| Horikawa, Y | 1 |
| Ohba, R | 1 |
| Oyake, J | 1 |
| Hatakeyama, N | 1 |
| Watanabe, S | 1 |
| Xiang, M | 1 |
| Zaccone, P | 1 |
| Di Marco, R | 1 |
| Magro, G | 1 |
| Di Mauro, M | 1 |
| Beltrami, B | 1 |
| Meroni, PL | 1 |
| Nicoletti, F | 1 |
2 other studies available for rolipram and Chemical and Drug Induced Liver Injury
| Article | Year |
|---|---|
Specific type IV phosphodiesterase inhibitor ameliorates thioacetamide-induced liver injury in rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Liver Diseases; Male; Phosphodiesterase Inhibitors; | 2005 |
Prevention by rolipram of concanavalin A-induced T-cell-dependent hepatitis in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Cell Movement; Chemical an | 1999 |